Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Brian Chun-Yuan Chan(University of Hong Kong), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Ka-Lun Kong(University of Hong Kong), Abe Ho-Ting Ngan(University of Hong Kong), Wing‐Ho Yung(Chinese University of Hong Kong), Johnson Y.N. Lau(University of Florida), Alex Pat-Chung Yeung(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Baptist University), Raymond Kar-Ching Hui(University of Hong Kong), Lok-Wun Chan(University of Hong Kong), Jinxia Zhang(Peking University), Ricky Zhang(Queen Mary Hospital), Arthur Chun-Fung Leung(University of Hong Kong), Harrison Ho Wai(University of Hong Kong), Hugo Pak-Yiu Fong(University of Hong Kong), Honglin Chen(University of Hong Kong), Tin-Lun Wong(Queen Mary Hospital), Tuen-Ching Chan(Queen Mary Hospital), Patrick Li(Queen Mary Hospital), Geo Chi-Ngo Yiu(University of Hong Kong), Kwok‐Hung Chan(University of Hong Kong), Louise Wing-Ki Tsang(University of Hong Kong)
Cited by 82
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k